Daily Highlights

Preview 24 Total

Bangkok beckons: An ISTH 2024 Congress welcome message from Chris Ward and Pantep Angchaisuksiri

Get involved with the SSC: An invitation from Joost Meijers and Kathleen Freson

ISTH announces recipients of its inaugural 2024 Outstanding Mentor Awards

A trailblazer in hematology research: David Lillicrap receives Harold R. Roberts Award

2024 Esteemed Career Awards

ISTH SSC announces 2024 grant award recipients

World Thrombosis Day honors 2023 global advocacy award winners

RPTH announces 2024 Editor’s Awards recipients

ISTH announces 2024 recipients of JTH Editors’ Awards

Grant Medal awardee Andreas Greinacher: Pioneering platelet researcher shapes future of hematology

ISTH Members Elect Council Class of 2030

Download and view the ISTH 2024 abstracts

BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at ISTH 2024 Congress

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

Exploring Bangkok: Your guide to the ISTH 2024 Congress

5 tips to maximize your professional social media presence

Follow the #ISTH2024 Social Media Ambassadors on their journey to Bangkok

First-timer's guide to the Congress

Download the ISTH 2024 App for access on the go

Visit Supported Symposia and Presentation Theaters for latest updates

Visit exhibition to discover the latest innovations, products and services

ISTH provides 298 Travel Awards to early career and Reach-the-World attendees

Forward together: A message from ISTH President Flora Peyvandi

Claim your virtual delegate bag with unique offers and promotions

ISTH 2024 Opening Ceremony welcomes thousands from around the globe

ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

Structural basis of prothrombin recognition by a Type-I anti-prothrombin antiphospholipid antibody revealed by cryo-EM

June 22, 2024 | Suresh Kumar, Ph.D.; Saint Louis University; St. Louis, MO, U.S.

Engineering a membrane-independent human prothrombinase through parsimonious mutation of factor Xa

June 22, 2024 | Fatma Işık Üstok, Ph.D.; University of Cambridge; Cambridge, U.K.

ISTH announces 2024 winners of Fundamental Research Career Development Awards

ISTH announces launch of new global education initiative in factor XI/XIa inhibition

Explore these Diversity, Equity and Inclusion (DEI) opportunities at the Congress

Love and science: Ton Lisman shares how an ISTH Congress connected him with his wife

ISTH Scientific and Standardization Committee (SSC): What it is and how you can get involved

ISTH Academy Live: Participate in this learning space at ISTH 2024

ISTH Congress shines a spotlight on diversity, equity and inclusion opportunities

Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open-label, randomized, controlled FRONTIER2 study

June 23, 2024 | Maria Elisa Mancuso M.D., Ph.D.; IRCCS Humanitas Research Hospital; Rozzano, Milan, Italy

How the ISTH Early Career Committee is shaping the future of thrombosis and hemostasis

Using artificial intelligence to disrupt the VWF-GPIBα interaction in platelet-type von Willebrand disease

June 23, 2024 | Thomas David Daniel Kazmirchuk, Ph.D.; Carleton University; Ottawa, Canada

30 years later: ISTH’s first president from the Asian-Pacific region, Hidehiko Saito, reflects on his term

Use of global coagulation assays to predict spontaneous major bleeding in chronic kidney disease patients

June 23, 2024 | Rowena Brook, M.B.B.S.; Northern Health; Melbourne, Australia

Thrombosis survivor Robyne Toseland shares her story: “It felt as though an elephant was sitting on my chest”

Novel FVIIIa-mimetic molecule with the potential to be the first oral treatment for severe hemophilia A

June 23, 2024 | Jacob Lund, Ph.D.; Novo Nordisk A/S; Bagsvaerd, Denmark

Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A

Canonical and non-canonical FXII functions synergistically drive ovarian cancer-associated thrombosis and tumor progression

June 23, 2024 | Dillon Bohinc, B.S.; Case Western Reserve University; Cleveland, OH, U.S.

Amyloid fibrils trigger plasma clotting by activating the intrinsic pathway of blood coagulation and can explain intracardiac thrombosis in transthyretin (ATTR) and Ig-light chain amyloidosis (AL)

June 23, 2024 | Alessia Dei Rossi, M.Sc., Ph.D. Student; University of Padua; Padua, Italy

Pick up a special print edition of RPTH at the ISTH Booth

EMA601, a novel humanized fab inhibits platelet glycoprotein VI with unprecedented potency and protects mice from arterial thrombosis and ischemic stroke

June 23, 2024 | Stefano Navarro, Ph.D.; University of Wuerzburg; Wuerzburg, Germany; and Bernhard Nieswandt, Ph.D.; University of Wuerzburg and Emfret Analytics GmbH; Wuerzburg, Germany; Eibelstadt Germany

Fibrinogenγ390-396A protects against high fat diet-induced obesity and MASLD by altering glycine metabolism

June 23, 2024 | Woosuk Steve Hur, Ph.D.; University of North Carolina at Chapel Hill; Chapel Hill, NC, U.S.

Terminal sialylation of commercial rVWF concentrate is responsible for attenuated macrophage-mediated clearance via the MGL receptor

June 23, 2024 | Ciara Byrne, Ph.D.; Royal College of Surgeons in Ireland; Dublin, Ireland

RPTH publishes Illustrated State-of-the-Art Capsules in conjunction with ISTH 2024

Evaluation of recombinant human prourokinase in the treatment of acute pulmonary embolism (ERUPTE): a randomized single-blinded multicenter phase 2 trial

June 23, 2024 | Zhi-Cheng Jing, M.D.; Guangdong Provincial People's Hospital; Guangzhou, China; and Chun-Yan Cheng, M.D., Ph.D.; Guangdong Provincial People's Hospital; Guangzhou, China